In a pandemic the pharmaceutical industry is hailed as a saviour; yet the industry is using the crisis to lock in its problematic, profit-maximising model. Pushing for public money with no-strings-attached, and stronger monopoly patent rules, the industry’s wish-list could restrict access to COVID-19 drugs and vaccines, prolonging the pandemic in the name of profit. Control over prices and access must not be left in private hands: health is a human right.
Related Articles
Corporate Europe Observatory – Will the EU Commission Stand Firm against Toxic Lobbying Pressure?
September 30, 2020
Mathew D. Rose
Corruption, EU politics, EU-Institutions, Lobbying, Regulation, Regulatory Capture, Revolving Door
0
Once again we see international corporations dictating EU policy. Germany was willing to sacrifice naming a German to head the European Central Bank realising the Ursula von der Leyen as EU Commission President would be […]
Bill Mitchell: Modern Monetary Theory is just plain old bad economics – Part 1
Concerning the British Labour Party and Modern Monetary Theory. Read here
OCCRP European Regulators Failed to Spot Suspicious Money Flooding Through Latvia’s Banks
September 21, 2020
Mathew D. Rose
Corruption, EU politics, EU-Institutions, Finance, Financial Institutions, Regulation, Regulatory Capture
0
European regulators gave the green light for international banks to handle billions of dollars that flowed from the former Soviet Union through Latvia’s banking sector, even as thousands of these transactions were being red-flagged to […]
Be the first to comment